Are Headaches a Side Effect of GLP-1 Medications
Novo Eyes Chronic Kidney Disease Approval Next Month Novo is seeking to expand the therapeutic reach of GLP-1 receptor agonists by looking at conditions closely related to the drug classs approved indications
Childhood maltreatment, behavioral adjustment, and molecular markers of cellular aging in preschool-aged children: a cohort study
Qiao Q, Ouwens MJ, Grandy S, Johnsson K, Kostev K
This subcellular distribution, the use of a highly specific antibody, and the identical distribution of the GLP-1R-IR and Glp1r mRNA-containing perikarya provide strong evidence that the neuronal GLP-1R expression pattern described here is specific
Beyond its antioxidant properties: Quercetin targets multiple signalling pathways in hepatocellular carcinoma in rats